121 related articles for article (PubMed ID: 30760936)
1. Hormonal imbalance and pituitary adenoma during antipsychotic treatment in an adolescent with bipolar affective disorder.
Rad F; Buica AM; Anghel GC; Stancu M; Dobrescu I
Riv Psichiatr; 2019; 54(1):37-39. PubMed ID: 30760936
[TBL] [Abstract][Full Text] [Related]
2. Effect of risperidone on prolactinoma--a case report.
Mendhekar DN; Jiloha RC; Srivastava PK
Pharmacopsychiatry; 2004 Jan; 37(1):41-2. PubMed ID: 14750048
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
Höfer P; Friedrich F; Vyssoki B; Spindelegger C; Schmook M; Barnas C; Lesch OM; Walter H
World J Biol Psychiatry; 2010 Aug; 11(5):759-61. PubMed ID: 20446883
[No Abstract] [Full Text] [Related]
6. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
Konopelska S; Quinkler M; Strasburger CJ; Ventz M
J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
[No Abstract] [Full Text] [Related]
7. Effect of risperidone on prolactinoma growth in a psychotic woman.
Pal JK; Sarino WA
Psychosom Med; 2000; 62(5):736-8. PubMed ID: 11020104
[TBL] [Abstract][Full Text] [Related]
8. Re: Prolactin levels and adverse events in patients treated with risperidone.
Denisov MF
J Clin Psychopharmacol; 2002 Oct; 22(5):538-40; author reply 540-1. PubMed ID: 12352286
[No Abstract] [Full Text] [Related]
9. Prolactin elevation with ziprasidone.
Lusskin SI; Cancro R; Chuang L; Jacobson J
Am J Psychiatry; 2004 Oct; 161(10):1925. PubMed ID: 15465997
[No Abstract] [Full Text] [Related]
10. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
11. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
12. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
[TBL] [Abstract][Full Text] [Related]
13. Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient.
Chen ST; Hsiao YL
J Clin Psychopharmacol; 2010 Feb; 30(1):78-80. PubMed ID: 20075655
[No Abstract] [Full Text] [Related]
14. Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports.
Haddad PM; Hellewell JS; Wieck A
J Psychopharmacol; 2001 Dec; 15(4):293-5. PubMed ID: 11769824
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review.
Madhusoodanan S; Steinberg LR; Coleman A; Bavli S
Curr Drug Saf; 2017; 12(1):19-21. PubMed ID: 27440143
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
[TBL] [Abstract][Full Text] [Related]
17. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Keller R; Mongini F
Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
[TBL] [Abstract][Full Text] [Related]
18. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic medication and marked hyperprolactinaemia: iatros or true prolactinoma?
Koves IH; Jarman FC; Cameron FJ
Acta Paediatr; 2004 Nov; 93(11):1543-7. PubMed ID: 15513588
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
